These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17219614)

  • 21. Anti-HIV agents. Delaying therapy--the pendulum swings back.
    TreatmentUpdate; 2002 Jan; 14(1):1-2. PubMed ID: 12141231
    [No Abstract]   [Full Text] [Related]  

  • 22. Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?
    Reekie J; Mocroft A; Sambatakou H; Machala L; Chiesi A; van Lunzen J; Clumeck N; Kirk O; Gazzard B; Lundgren JD;
    AIDS; 2008 Nov; 22(17):2381-90. PubMed ID: 18981778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.
    Lima VD; Harrigan R; Murray M; Moore DM; Wood E; Hogg RS; Montaner JS
    AIDS; 2008 Nov; 22(17):2371-80. PubMed ID: 18981777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-HIV agents. Viral load blips linked to adherence.
    TreatmentUpdate; 2008 Jan; 20(1):4-6. PubMed ID: 18323003
    [No Abstract]   [Full Text] [Related]  

  • 26. Guidelines for kidney transplantation in patients with HIV disease.
    Bhagani S; Sweny P; Brook G;
    HIV Med; 2006 Apr; 7(3):133-9. PubMed ID: 16494626
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-HIV agents. Rescue therapy.
    TreatmentUpdate; 2000 Mar; 12(2):5-6. PubMed ID: 12125620
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-HIV agents. Some researchers call for early HIV therapy.
    TreatmentUpdate; 2007 Jan; 19(1):1-2. PubMed ID: 17390476
    [No Abstract]   [Full Text] [Related]  

  • 29. Are short interruptions safe?
    Nagy GS
    AIDS Clin Care; 2002 May; 14(5):47. PubMed ID: 12004880
    [No Abstract]   [Full Text] [Related]  

  • 30. Anti-HIV agents. Why are drug holidays dangerous?
    TreatmentUpdate; 2009 Jan; 21(1):6-7. PubMed ID: 19248285
    [No Abstract]   [Full Text] [Related]  

  • 31. Interleukin 2 and HIV RNA Levels.
    Go R; Steigbigel R
    Arch Intern Med; 2007 Oct; 167(19):2144-5; author reply 2145. PubMed ID: 17954814
    [No Abstract]   [Full Text] [Related]  

  • 32. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
    AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-HIV agents. Receptor blocker (SCH 532706) enters clinical trials.
    TreatmentUpdate; 2008 Mar; 20(2):8-9. PubMed ID: 18663778
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-HIV agents. Should HAART begin right after an HIV diagnosis?
    TreatmentUpdate; 2009; 21(3):2-3. PubMed ID: 19630120
    [No Abstract]   [Full Text] [Related]  

  • 35. Intermittent antiretroviral therapy in patients with controlled HIV infection.
    Marchou B; Tangre P; Charreau I; Izopet J; Girard PM; May T; Ragnaud JM; Aboulker JP; Molina JM;
    AIDS; 2007 Feb; 21(4):457-66. PubMed ID: 17301564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The next big challenge: managing HIV infection in an age of higher resistance.
    AIDS Alert; 2001 Dec; 16(12):153, 155-7. PubMed ID: 11768873
    [No Abstract]   [Full Text] [Related]  

  • 37. Complications & side effects. Can statins be used as anti-HIV drugs?
    TreatmentUpdate; 2004; 16(7):9. PubMed ID: 17219689
    [No Abstract]   [Full Text] [Related]  

  • 38. Directly observed therapy programmes for anti-retroviral treatment amongst injection drug users in Vancouver: access, adherence and outcomes.
    Tyndall MW; McNally M; Lai C; Zhang R; Wood E; Kerr T; Montaner JG
    Int J Drug Policy; 2007 Aug; 18(4):281-7. PubMed ID: 17689376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
    Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
    Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.